Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.

Conclusion: Stromal IL-2 is associated with higher a neutrophil/lymphocyte ratio, suggesting a worse prognosis in ovarian cancer and its role in tumor immunology; a neutrophil/lymphocyte ratio > 2.6 is associated with more advanced stages of malignant ovarian neoplasia. PMID: 31388197 [PubMed - in process]
Source: Pathologica - Category: Pathology Tags: Pathologica Source Type: research